Publications by Wim Van Criekinge.

2019

MGMT promoter methylation cutoff with safety margin for selecting glioblastoma patients into trials omitting temozolomide : a pooled analysis of four clinical trials
M. Hegi, E. Genbrugge, T. Gorlia, R. Stupp, M. Gilbert, O. Chinot, L. Nabors, G. Jones, W. Van Criekinge, J. Straub and M. Weller
(2019) CLINICAL CANCER RESEARCH, 25,

MEXPRESS update 2019
A. Koch, J. Jeschke, W. Van Criekinge, M. vanĀ Engeland and T. De Meyer
(2019) NUCLEIC ACIDS RESEARCH, 47,

2018

Integrated transcriptomic and epigenomic analysis of ovarian cancer reveals epigenetically silenced GULP1
L. Maldonado, M. Brait, E. Izumchenko, S. Begum, A. Chatterjee, T. Sen, M. Loyo, A. Barbosa, M. Poeta, E. Makarev, A. Zhavoronkov, V. Fazio, R. Angioli, C. Rabitti, M. Ongenaert, W. Van Criekinge, M. Noordhuis, P. de Graeff, G. Wismann, A. van der Zee and M. Hoque
(2018) CANCER LETTERS, 433,

A comprehensive overview of genomic imprinting in breast and its deregulation in cancer
T. Goovaerts, S. Steyaert, C. Vandenbussche, J. Galle, O. Thas, W. Van Criekinge and T. De Meyer
(2018) NATURE COMMUNICATIONS, 9, 4120

Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from type2 diabetes patients : rescue by Ī±-ketoglutarate and TET-TDG functional reactivation
F. Spallotta, C. Cencioni, S. Atlante, D. Garella, M. Cocco, M. Mori, R. Mastrocola, C. Kuenne, S. Guenther, S. Nanni, V. Azzimato, S. Zukunft, A. Kornberger, D. Sueruen, F. Schnuetgen, H. von Melchner, A. Di Stilo, M. Aragno, M. Braspenning, W. Van Criekinge, M. De Blasio, R. Ritchie, G. Zaccagnini, F. Martelli, A. Farsetti, I. Fleming, T. Braun, A. Beiras-Fernandez, B. Botta, M. Collino, M. Bertinaria, A. Zeiher and C. Gaetano
(2018) CIRCULATION RESEARCH, 122,

Exploratory analysis of the human breast DNA methylation profile upon soymilk exposure
L. Coussement, S. Bolca, W. Van Criekinge, G. Trooskens, K. Mensaert, K. Poels, N. Roche, P. Blondeel, L. Godderis, H. Depypere and T. De Meyer
(2018) SCIENTIFIC REPORTS, 8, 13617

Epigenetic markers in circulating cell-free DNA as prognostic markers for survival of castration-resistant prostate cancer patients
R. Hendriks, S. Dijkstra, F. Smit, J. Vandersmissen, H. Van de Voorde, P. Mulders, I. van Oort, W. Van Criekinge and J. Schalken
(2018) PROSTATE, 78,

Evaluation of bisulfite kits for DNA methylation profiling in terms of DNA fragmentation and DNA recovery using digital PCR
S. Kint, W. De Spiegelaere, J. De Kesel, L. Vandekerckhove and W. Van Criekinge
(2018) PLOS ONE, 13, e0199091

An update on sORFs.org : a repository of small ORFs identified by ribosome profiling
V. Olexiouk, W. Van Criekinge and G. Menschaert
(2018) NUCLEIC ACIDS RESEARCH, 46,

Analysis of DNA methylation in cancer : location revisited
A. Koch, S. Joosten, Z. Feng, T. de Ruijter, M. Draht, V. Melotte, K. Smits, J. Veeck, J. Herman, L. Van Neste, W. Van Criekinge, T. De Meyer and M. van Engeland
(2018) NATURE REVIEWS CLINICAL ONCOLOGY, 15,